Jim Cramer explains what to watch ahead of the open, including Visa and MasterCard.» Read More
It's a major week for earnings. What they say about the state of the market and where it's headed, with CNBC's Jackie DeAngelis and the Futures Now Traders, Jim Iuorio & Jeff Kilburg, both at the CME.
CNBC's Jim Cramer explains why he is watching cannabis stock GW Pharma.
Jim Cramer explains what to watch ahead of the open, including McDonald's and a bullish upgrade for Facebook.
Chris Baggini of Turner Titan Fund, explains his top three stock picks for investors right now. He says Facebook's advertising model is "very strong."
Mad Money host Jim Cramer explains why picking a stock because it is "sitting on a mountain of cash" could cause an investor to get crushed.
Whether you’re rich as Midas, poor as a pauper or in-between, Cramer can find you a stock that fits your budget, perfectly.
Secondary stock offerings do not always mean a company is in trouble, Mad Money host Jim Cramer explains.
Mad Money host Jim Cramer explains how low estimates from Caterpillar in 2009 and JPMorgan in 2012 signaled the bottoming of their stocks.
The Fast Money traders share their final trades of the day.
The Fast Money traders take a look at today's biggest market movers.
Sometimes terrible earnings beget fantastic investment opportunities. Cramer thinks this is one of those times.
Dennis Gartman of the Gartman Letter shares his position on equities and the best way to play a possible merger between Barrick Gold and Newmont Mining.
Michael Patcher, Wedbush Securities, discusses metrics hit by Netflix in its quarterly earnings report.
Mike Weinstein, JPMorgan senior medical technology analyst, looks at the growth acceleration story of Covidien and weighs in on Valeant's potential acquisition of Allergan.
CNBC's Meg Tirrell reports on the statement released by Valeant about its potential acquisition of Allergan.
The FM traders discuss how the departure of Ford's current CEO Alan Mulally will impact the stock, as well as the appointment of COO Mark Fields as his replacement.
Tony Wible, Janney Capital Markets, provides reaction to Netflix's quarterly numbers.
Dissecting Netflix's quarterly numbers and "tremendous" international growth, with the "Fast Money" traders.
CNBC's David Faber reports the latest on Bill Ackman and Valeant's hostile effort to acquire Allergan.
Abigail Doolittle, Peak Theories founder & analyst, and JJ Burns, JJ Burns & Company president, share their market predictions and which stocks are poised nicely.